NANO MRNA Co., Ltd.

4571・Growth Market・Pharmaceuticals

Official website

NANO MRNA Co., Ltd.

4571・Growth Market・Pharmaceuticals

Official website

NANO MRNA Co., Ltd.4571

Reference Indicators

Market Cap

81¥100M

P/E (Forecast)

—

P/B

2.3x

Dividend Yield (Forecast)

0.00%

ROE

-27.7%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	264	202	135	108	174
Cost of Sales	41	42	24	30	21
Gross Profit	222	159	110	78	153
SG&A Expenses	2,283	1,405	975	833	1,119
Operating Income	-2,061	-1,246	-864	-755	-965
Non-operating Income	144	156	125	73	147
Non-operating Expenses	8	14	11	5	48
Ordinary Income	-1,925	-1,104	-749	-687	-866
Extraordinary Income	61	71	43	—	—
Extraordinary Losses	15	274	71	145	73
Pre-tax Income	-1,879	-1,308	-777	-832	-940
Income Taxes	2	2	2	2	3
Net Income	-1,881	-1,310	-780	-835	-943
EBITDA	-2,057	-1,245	-863	-755	-965
Gross Margin	84.4%	78.9%	81.9%	72.0%	87.8%
Operating Margin	-780.6%	-616.3%	-637.9%	-696.1%	-553.6%
ROA	-26.4%	-22.7%	-15.4%	-20.9%	-16.0%
ROE	-33.7%	-30.9%	-22.2%	-30.6%	-27.7%